Ibuzatrelvir clinical trials
Also written PF-07817883.
How each study uses ibuzatrelvir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ibuzatrelvir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2023 (4)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 2 in phase 3
Studies that test ibuzatrelvir, phase 3 first.
- Sep 2027A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedPhase 3 · Pfizer
- Oct 2027A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseasePhase 3 · Pfizer
Studies
Open first, then newest update. How each study uses ibuzatrelvir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe DiseaseRecruitingPhase 3PfizerNCT06679140Written as ibuzatrelvir
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely ImmunocompromisedRecruitingPhase 3PfizerNCT07013474Written as ibuzatrelvir
- A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese AdultsCompletedPhase 1PfizerNCT07235137Written as Ibuzatrelvir
- A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.CompletedPhase 1PfizerNCT06586216Written as PF-07817883
- A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy AdultsCompletedPhase 1PfizerNCT06646042Written as ibuzatrelvir
- A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult VolunteersCompletedPhase 1PfizerNCT06122194Written as Drug: PF-07817883
- A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy PeopleCompletedPhase 1PfizerNCT05580003Written as PF-07817883
- A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not HospitalizedCompletedPhase 2PfizerNCT05799495Written as PF-07817883
- A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults.CompletedPhase 1PfizerNCT05822440Written as PF-07817883
- A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-07817883.CompletedPhase 1PfizerNCT05884554Written as PF-07817883
Codes
What other systems call ibuzatrelvir · ClinicalTrials.gg INT017112
- UNII (FDA) KZ2X7QH2VTIBUZATRELVIRConfirmed FDA, Wikidata
- Wikidata Q127415685ibuzatrelvirConfirmed FDA, Wikidata
- NCI Thesaurus C203104IbuzatrelvirOne source FDA
- DrugBank DB19451One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | KZ2X7QH2VT | IBUZATRELVIR | Confirmed FDA, Wikidata |
| Wikidata | Q127415685 | ibuzatrelvir | Confirmed FDA, Wikidata |
| NCI Thesaurus | C203104 | Ibuzatrelvir | One source FDA |
| DrugBank | DB19451 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.